Suture guidance
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of resorbable suture 510(k)s should include a resorption profile based on in vivo or in vitro studies that illustrates the tensile strength of the suture for a clinically significant period of time, depending on the suture's intended use, guidance issued Aug. 10 advises
You may also be interested in...
Surgical Sutures To Be Class II With Special Controls Under Proposed Rule
Comments on an FDA guidance outlining special controls for eight Class II surgical sutures are due March 19, 2003
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.